Relcovaptan (SR-49059) is a non-
peptide vasopressin receptor antagonist, selective for the
V1a subtype. It has shown positive initial results for the treatment of
Raynaud's disease and
dysmenorrhoea, and as a
tocolytic,
although it is not yet approved for clinical use.
References
Vasopressin receptor antagonists
{{systemic-hormonal-drug-stub